• Pharvaris moves closer to bringing second oral on-demand HAE therapy to US FirstWord Pharma Mon, 06 Jul 2026 14:27:07 GMT
• kalvista pharmaceuticals updates pipeline outlook as hereditary angioedema work advances Ad-hoc-news.de Fri, 03 Jul 2026 20:33:48 GMT
• kalvista pharmaceuticals inc (ham:4xc1) stock price, trades & news GuruFocus Mon, 29 Jun 2026 07:56:55 GMT
• enterprise value to revenue forward of kalvista pharmaceuticals, inc. – swb:4xc1 TradingView Fri, 26 Jun 2026 17:50:45 GMT
• price to earnings forward of kalvista pharmaceuticals, inc. – swb:4xc1 TradingView Fri, 26 Jun 2026 15:07:28 GMT
• KalVista Pharmaceuticals, Inc. Actuals & Estimates (SWB:4XC1) TradingView Fri, 26 Jun 2026 11:26:31 GMT
• price to book forward of kalvista pharmaceuticals, inc. – swb:4xc1 TradingView Fri, 26 Jun 2026 06:22:04 GMT
• kalvista pharmaceuticals stock - analyst sentiment and long-term strategy under the spotlight AD HOC NEWS Sat, 20 Jun 2026 15:43:02 GMT
• kalvista pharmaceuticals inc (kalv) dividends & stock splits: historical payouts and event timeline TradingKey Thu, 18 Jun 2026 02:54:23 GMT
• kalvista pharmaceuticals inc (kalv) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 02:20:58 GMT
• kalvista pharmaceuticals inc (kalv) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 20:18:39 GMT
• kalvista pharmaceuticals stock (us48530t1051): acquisition by chiesi and latest ownership moves in f AD HOC NEWS Tue, 16 Jun 2026 14:53:58 GMT
• Chiesi Group Acquires KalVista Pharmaceuticals for $1.9 Billion CHEManager Tue, 16 Jun 2026 07:00:00 GMT
• A Framingham biotech just became a $1.9B Italian acquisition. Here’s the drug behind it MassLive Tue, 16 Jun 2026 07:00:00 GMT
• kalvista pharma: fundamental analysis and financial ratings | kalv | us4834971032 marketscreener.com Mon, 15 Jun 2026 19:43:36 GMT
• kalvista pharma: performance & quotes, kalv stock price on nasdaq exchange marketscreener.com Mon, 15 Jun 2026 19:34:01 GMT
• KalVista Pharmaceuticals, Inc.(NasdaqGM:KALV) dropped from Russell 2000 Dynamic Index marketscreener.com Sun, 14 Jun 2026 22:00:00 GMT
• Chiesi Group Completes Acquisition Of KalVista Pharmaceuticals Pulse 2.0 Sun, 14 Jun 2026 07:00:00 GMT
• KalVista Pharmaceuticals, Inc.(NasdaqGM: KALV) dropped from Russell Microcap Index marketscreener.com Sun, 14 Jun 2026 07:00:00 GMT
• key facts: kalvista notes convert to $1,606.28; chiesi buys kalv at $27 TradingView Fri, 12 Jun 2026 07:13:35 GMT
• Italian company completes $1.9B acquisition of Framingham pharma firm Worcester Business Journal Fri, 12 Jun 2026 07:00:00 GMT
• Chiesi Group Completes $1.64 Billion Acquisition Of KalVista Pharmaceuticals Pulse 2.0 Fri, 12 Jun 2026 07:00:00 GMT
• kalvista (kalv) director’s stock options cancelled or cash-settled in chiesi takeover Stock Titan Thu, 11 Jun 2026 20:38:51 GMT
• kalvista (kalv) director’s option cancelled and cashed out in chiesi deal Stock Titan Thu, 11 Jun 2026 20:30:21 GMT
• kalvista (nasdaq: kalv) ceo equity cancelled for $27 cash deal Stock Titan Thu, 11 Jun 2026 20:27:44 GMT
• kalvista (nasdaq: kalv) cdo disposes equity in $27-per-share chiesi deal Stock Titan Thu, 11 Jun 2026 20:26:41 GMT
• chiesi completes acquisition of kalvista, expanding rare disease portfolio with ekterly citybiz Thu, 11 Jun 2026 14:30:16 GMT
• Chiesi Group Completes Acquisition of KalVista Pharmaceuticals Business Wire Thu, 11 Jun 2026 07:00:00 GMT
• Chiesi Group Acquires KalVista Pharmaceuticals for $1.9B Contract Pharma Thu, 11 Jun 2026 07:00:00 GMT
• KalVista Pharmaceuticals Announced Transfer or Voluntary Withdrawal of Listing TradingView Thu, 11 Jun 2026 07:00:00 GMT
• KalVista Pharmaceuticals Sets $1,606.28 Cash Conversion for 3.25% Converts via Supplemental Indenture TradingView Thu, 11 Jun 2026 07:00:00 GMT
• Kalvista Pharmaceuticals, Inc. Announces Management Changes marketscreener.com Thu, 11 Jun 2026 07:00:00 GMT
• KalVista (NASDAQ: KALV) director options cashed out, canceled in Chiesi deal Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• KalVista (NASDAQ: KALV) CMO’s stock, RSUs and options cancelled in $27-per-share Chiesi merger cleanup Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• KalVista Pharmaceuticals (KALV) CFO exits equity as Chiesi cash deal closes Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• Chiesi completes acquisition of KalVista for $27 per share Investing.com Thu, 11 Jun 2026 07:00:00 GMT
• KalVista (NASDAQ: KALV) COO’s RSUs and options cashed out in Chiesi merger Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• KalVista (KALV) acquisition closes; 43.15M shares tendered at $27.00 Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• KalVista (KALV) director has 45,000 stock options cashed out in Chiesi merger terms Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• Chiesi deal cancels options for KalVista (KALV) director Edward Unkart Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• KalVista Pharmaceuticals (NASDAQ: KALV) removes Common Stock from Nasdaq Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• KalVista (NASDAQ: KALV) taken private in $27 cash sale to Chiesi Group Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• kalvista (nasdaq: kalv) deregisters s-3 securities after merger Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• kalvista (kalv) acquired by chiesi for $27.00 per share, deal closes Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• press release: chiesi group completes acquisition of kalvista pharmaceuticals Moomoo Thu, 11 Jun 2026 07:00:00 GMT
• kalvista (nasdaq: kalv) director’s options canceled and cashed out in $27 chiesi deal Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• kalvista (kalv) cco sweeny cashes out stock, rsus and options in chiesi buyout Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• kalvista (kalv) director closes out 91,000 options in $27-per-share chiesi merger Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• kalvista pharmaceuticals stock hits 52-week high at $27.00 by investing.com Investing.com Australia Thu, 11 Jun 2026 02:53:37 GMT
• kalvista pharmaceuticals, inc.(nasdaqgm:kalv) dropped from s&p biotechnology select industry index marketscreener.com Thu, 11 Jun 2026 00:26:16 GMT
• KalVista Pharmaceuticals, Inc.(NasdaqGM: KALV) dropped from S&P TMI Index marketscreener.com Thu, 11 Jun 2026 00:25:25 GMT
• capital world investors sells 369,004 shares of kalvista pharmaceuticals, inc. $kalv MarketBeat Wed, 10 Jun 2026 08:08:24 GMT
• kalvista pharmaceuticals stock hits 52-week high at $27.00 Investing.com Wed, 10 Jun 2026 07:00:00 GMT
• kalvista pharmaceuticals, inc.(nasdaqgm: kalv) dropped from nasdaq composite index marketscreener.com Wed, 10 Jun 2026 07:00:00 GMT
• kalvista pharmaceuticals, inc.(nasdaqgm:kalv) dropped from nasdaq biotechnology index marketscreener.com Tue, 09 Jun 2026 22:00:00 GMT
• kalvista pharmaceuticals(delisted) (kalv) stock forum and discussion Moomoo Tue, 09 Jun 2026 07:44:55 GMT
• cost of goods sold of kalvista pharmaceuticals, inc. – xetr:4xc1 TradingView Sat, 06 Jun 2026 22:41:08 GMT
• kalvista pharmaceuticals, inc. balance sheet – xetr:4xc1 TradingView Sat, 06 Jun 2026 17:54:24 GMT
• kalvista pharmaceuticals, inc. revenue breakdown – xetr:4xc1 TradingView Sat, 06 Jun 2026 17:26:13 GMT
• kalvista pharmaceuticals (kalv) upgraded to buy: what does it mean for the stock? MSN Fri, 05 Jun 2026 00:42:30 GMT
• injectable treatments for hae attacks may add stress for children Angioedema News Thu, 04 Jun 2026 18:21:33 GMT
• kalvista pharmaceuticals stock hits 52-week high at 26.77 usd Investing.com Thu, 04 Jun 2026 10:47:41 GMT
• KalVista Pharmaceuticals (KALV) Upgraded to Buy: What Does It Mean for the Stock? Yahoo Finance Thu, 04 Jun 2026 07:00:00 GMT
• Physician Views Preview: On eve of approval anniversary and Chiesi takeover, is Ekterly living up to expectations? FirstWord Pharma Wed, 03 Jun 2026 07:00:00 GMT
• women of distinction 2026: nicole sweeny Medical Marketing and Media Mon, 01 Jun 2026 12:14:27 GMT
• Assessing KalVista Pharmaceuticals (KALV) Valuation After A Strong Year Of Shareholder Returns simplywall.st Mon, 01 Jun 2026 07:00:00 GMT
• kalvista (kalv) discloses two shareholder suits, reiterates $27.00/share deal Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• chiesi (kalv) offers $27.00/share; hsr, german and italian clearances noted Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• kalvista's (kalv) chief development officer sells 33,800 shares for $905,000 AOL.com Mon, 01 Jun 2026 00:18:09 GMT
• KalVista's (KALV) Chief Development Officer Sells 33,800 Shares for $905,000 The Motley Fool Sun, 31 May 2026 07:00:00 GMT
• kalvista pharmaceuticals stock hits 52-week high at $26.86 by investing.com Investing.com Nigeria Sat, 30 May 2026 02:39:40 GMT
• kalvista posts $49.1 million in ekterly revenue during eight-month transition period MSN Sat, 30 May 2026 00:47:28 GMT
• kalvista pharmaceuticals chief development officer sold shares worth over $905k TradingView Fri, 29 May 2026 20:10:01 GMT
• christopher yea of kalvista (kalv) exercises options and sells shares Stock Titan Fri, 29 May 2026 07:00:00 GMT
• kalvista pharmaceuticals stock hits 52-week high at $26.86 Investing.com Fri, 29 May 2026 07:00:00 GMT
• kalvista chief development officer yea sells $905,224 in shares Investing.com Fri, 29 May 2026 07:00:00 GMT
• kalvista (kalv) highlights challenges of injectable hae treatmen GuruFocus Thu, 28 May 2026 18:35:08 GMT
• KalVista Pharmaceuticals Presents New Data Highlighting the Burden of Injectable On-Demand Treatment in Young Children with Heredi... Business Wire Thu, 28 May 2026 07:00:00 GMT
• kalvista pharmaceuticals data highlights challenges of injectable hae treatments for young children geneonline.com Thu, 28 May 2026 07:00:00 GMT
• kalvista (nasdaq: kalv) cmo exercises rsus, sells shares for taxes Stock Titan Wed, 27 May 2026 07:00:00 GMT
• kalvista (nasdaq: kalv) cdo yea sells 1,966 shares to cover rsu taxes Stock Titan Wed, 27 May 2026 07:00:00 GMT
• kalvista (nasdaq: kalv) cco exercises rsus, sells shares to cover taxes Stock Titan Wed, 27 May 2026 07:00:00 GMT
• 33,800-share form 144 notice for kalv (nasdaq: kalv) from an insider Stock Titan Wed, 27 May 2026 07:00:00 GMT
• kalvista pharmaceuticals cmo audhya sells $71,916 in stock by investing.com Investing.com South Africa Wed, 27 May 2026 07:00:00 GMT
• kalvista cfo brian piekos sells $39,881 in company stock by investing.com Investing.com South Africa Wed, 27 May 2026 01:21:31 GMT
• kalvista ceo benjamin palleiko sells $292,646 in common stock by investing.com Investing.com Nigeria Wed, 27 May 2026 00:48:29 GMT
• kalvista pharmaceuticals cdo sells shares worth $63,157 by investing.com Investing.com Nigeria Wed, 27 May 2026 00:33:37 GMT
• kalvista cco sweeny sells shares worth $49,845 by investing.com Investing.com India Wed, 27 May 2026 00:17:36 GMT
• kalvista pharmaceuticals cmo audhya sells $71,916 in stock Investing.com Tue, 26 May 2026 23:37:00 GMT
• kalvista ceo benjamin palleiko sells $292,646 in common stock Investing.com Tue, 26 May 2026 07:00:00 GMT
• kalvista pharmaceuticals cdo sells shares worth $63,157 Investing.com Tue, 26 May 2026 07:00:00 GMT
• kalvista ceo sells shares to cover rsu taxes | kalv insider trading Stock Titan Tue, 26 May 2026 07:00:00 GMT
• kalvista cfo brian piekos sells $39,881 in company stock Investing.com Tue, 26 May 2026 07:00:00 GMT
• kalvista (nasdaq: kalv) cdo logs rsu vesting and small tax-driven share sale Stock Titan Tue, 26 May 2026 07:00:00 GMT
• kalvista (kalv) cfo sells shares after rsu vesting to cover taxes Stock Titan Tue, 26 May 2026 07:00:00 GMT
• kalvista (kalv) cmo exercises 6,250 rsus and sells shares to cover taxes Stock Titan Tue, 26 May 2026 07:00:00 GMT
• kalvista (kalv) cco sells 1,861 shares in tax-related rsu sale Stock Titan Tue, 26 May 2026 07:00:00 GMT
• why (kalv) price action is critical for tactical trading Stock Traders Daily Mon, 25 May 2026 06:18:03 GMT
• frazier life sciences funds (nasdaq: kalv) disclose updated kalvista ownership Stock Titan Thu, 21 May 2026 07:00:00 GMT
• kalvista pharmaceuticals investor alert: kahn swick & foti, llc investigates adequacy of price and process in proposed sale of kal... Business Wire Tue, 19 May 2026 07:00:00 GMT
• kalvista (kalv) cdo sells shares to cover rsu tax obligations Stock Titan Tue, 19 May 2026 07:00:00 GMT
• kalvista (kalv) ceo nets rsu shares after tax-related stock sale Stock Titan Tue, 19 May 2026 07:00:00 GMT
• kalvista pharmaceuticals (kalv) cmo covers rsu taxes with 1,032-share sale Stock Titan Tue, 19 May 2026 07:00:00 GMT
• kalvista pharmaceuticals (kalv) price target decreased by 12.99% to 30.47 MSN Mon, 18 May 2026 12:46:41 GMT
• kalvista pharmaceuticals (kalv) cmo covers rsu taxes with 1,032-share sale Stock Titan Mon, 18 May 2026 07:00:00 GMT
• the $1.9 billion bet: chiesi acquires kalvista, redefining rare disease value Kavout Sun, 17 May 2026 22:40:16 GMT
• italian pharma group chiesi to buy us peer kalvista for $1.9 billion MSN Sun, 17 May 2026 22:19:50 GMT
• kalvista pharmaceuticals stock (us48530t1051): data readout shock and financing reshape the story AD HOC NEWS Sun, 17 May 2026 19:18:24 GMT
• kalvista pharmaceuticals (kalv) price target decreased by 12.99% to 30.47 MSN Sun, 17 May 2026 14:58:51 GMT
• assessing kalvista pharmaceuticals (kalv) valuation after strong recent share price momentum simplywall.st Sun, 17 May 2026 07:00:00 GMT
• merger agreement with chiesi puts strategic handcuffs on kalvista, raising execution and liquidity risks TipRanks Sat, 16 May 2026 06:10:44 GMT
• needham maintains kalvista pharmaceuticals(kalv.us) with hold rating 富途牛牛 Fri, 15 May 2026 12:31:00 GMT
• point72 entities report 4.2% stake in kalvista (nasdaq: kalv) — 2.14m shares Stock Titan Fri, 15 May 2026 07:00:00 GMT
• italian pharma group chiesi to buy us peer kalvista for $1.9 billion MSN Fri, 15 May 2026 03:00:22 GMT
• brodsky & smith investigates fiduciary duty breaches in mergers of kalvista, thermon, sila, and lisata. Pluang Fri, 15 May 2026 01:05:13 GMT
• kalvista posts $49.1 million in ekterly revenue during eight-month transition period MSN Thu, 14 May 2026 21:51:11 GMT
• BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of GlobeNewswire Thu, 14 May 2026 07:00:00 GMT
• chiesi to acquire kalvista (nasdaq: kalv) in $27 per share cash deal Stock Titan Thu, 14 May 2026 07:00:00 GMT
• kalvista ceo benjamin palleiko sells $88,730 in company stock by investing.com Investing.com India Thu, 14 May 2026 03:16:53 GMT
• Kalvista Pharmaceuticals stock hits 52-week high at $26.85 Investing.com Wed, 13 May 2026 07:00:00 GMT
• chiesi (nasdaq: kalv) offers $27.00 per share to acquire kalvista Stock Titan Wed, 13 May 2026 07:00:00 GMT
• kalvista (kalv) ceo palleiko sells shares to cover taxes after rsu vesting Stock Titan Wed, 13 May 2026 07:00:00 GMT
• silverarc (kalv) files 2.88m-share schedule 13g stake disclosure Stock Titan Wed, 13 May 2026 07:00:00 GMT
• kalvista ceo benjamin palleiko sells $88,730 in company stock Investing.com Wed, 13 May 2026 07:00:00 GMT
• kalvista (nasdaq: kalv) board backs $27 cash tender offer and planned merger Stock Titan Wed, 13 May 2026 07:00:00 GMT
• citizens maintains kalvista pharmaceuticals (kalv) market outperform recommendation MSN Sun, 10 May 2026 10:04:25 GMT
• f m investments llc purchases 37,486 shares of kalvista pharmaceuticals, inc. $kalv MarketBeat Sun, 10 May 2026 07:00:00 GMT
• stifel maintains kalvista pharmaceuticals(kalv.us) with hold rating, maintains target price $27 富途牛牛 Sun, 10 May 2026 05:01:09 GMT
• stifel downgrades kalvista pharmaceuticals(kalv.us) to hold rating, cuts target price to $27 富途牛牛 Sun, 10 May 2026 04:32:03 GMT
• a look at kalvista pharmaceuticals (kalv) valuation after a strong year of share price gains Yahoo Finance Sun, 10 May 2026 00:24:00 GMT
• A Look At KalVista Pharmaceuticals (KALV) Valuation After A Strong Year Of Share Price Gains Yahoo Finance Sat, 09 May 2026 07:00:00 GMT
• stock market today, april 29: kalvista pharmaceuticals surges on chiesi group acquisition announcement AOL.com Fri, 08 May 2026 23:55:18 GMT
• kalvista pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4) Quantisnow Fri, 08 May 2026 22:46:52 GMT
KalVista Pharmaceuticals, Inc(NASDAQ:KALV) 
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HA...
Website: http://www.kalvista.com
Founded: 2004
Full Time Employees: 56
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends